| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $96.7M | +47.3% |
| Cost of Revenue | $44.4M | +21.8% |
| Gross Profit | $52.3M | +79.1% |
| R&D Expense | $14.4M | +156.8% |
| SG&A Expense | $31.2M | +22.2% |
| Operating Income | -$111.6M | -89.5% |
| Interest Expense | $900K | — |
| Pre-tax Income | -$110.3M | -90.0% |
| Income Tax | -$110K |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.4M | -61.0% |
| Accounts Receivable | $21.7M | -22.9% |
| Inventory | $10.8M | -33.6% |
| Current Assets | $59.9M | -43.1% |
| Total Assets | $137.6M | -48.2% |
| Current Liabilities | $64.4M | -41.1% |
| Long-term Debt | $15.0M | +8233.3% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.8M | -11.0% |
| Investing Cash Flow | -$3.2M | -16.8% |
| Financing Cash Flow | $1.5M | -95.0% |
| -142.5% |
| Net Income | -$110.2M | -89.0% |
| EPS (Basic) | -$3.39 | +2.6% |
| EPS (Diluted) | -$3.75 | -7.8% |
| Total Liabilities |
| $91.5M |
| -28.5% |
| Stockholders' Equity | $46.1M | -66.5% |